Related Experiment Video
Updated: Feb 9, 2026

Dual CRISPR-Interference Strategy for Targeting Synthetic Lethal Interactions Between Non-Coding RNAs in Cancer Cells
Published on: May 30, 2025
Exosomal Non-Coding RNAs: Diagnostic, Prognostic and Therapeutic Applications in Cancer
Marc D Bullock1,2,3, Andreia M Silva4,5,6, Pinar Kanlikilicer-Unaldi7
1Cancer sciences unit, University of Southampton School of Medicine, Southampton, SO16 6YD, UK. MDBullock@mdanderson.org.
Non-coding RNAs (ncRNAs) within exosomes show promise as cancer biomarkers and therapeutic targets. These tiny vesicles protect ncRNAs in bodily fluids, aiding in cancer diagnostics, prognostics, and drug delivery strategies.
Area of Science:
- Oncology
- Molecular Biology
- Biochemistry
Background:
- Non-coding RNAs (ncRNAs), including microRNAs and long non-coding RNAs, are critical regulators frequently dysregulated in cancer.
- Exosomes, extracellular vesicles derived from endosomes, play significant roles in cancer progression and metastasis.
- Exosomes encapsulate ncRNAs, shielding them from degradation in bodily fluids, making them valuable diagnostic and prognostic indicators.
Purpose of the Study:
- To review the clinical relevance of exosomal ncRNAs in cancer.
- To explore the diagnostic and prognostic potential of exosomal ncRNAs.
- To examine the therapeutic applications of exosomal ncRNAs, including drug delivery.
Main Methods:
- Literature review focusing on exosomal ncRNAs in cancer.
- Analysis of current research on the role of ncRNAs in cancer development and metastasis.
- Examination of exosome biogenesis, cargo loading, and intercellular communication.
Main Results:
- Exosomal ncRNAs are altered in a tissue- and stage-specific manner in various cancers.
- The protective nature of exosomes enhances the stability of ncRNAs in circulation.
- Exosomes can be engineered for targeted delivery of therapeutic ncRNAs.
Conclusions:
- Exosomal ncRNAs represent a promising source for cancer diagnostics and prognostics.
- The natural ncRNA-carrying capacity of exosomes offers potential for novel cancer therapies.
- Targeting exosomal ncRNAs may lead to innovative strategies for cancer treatment.
More Related Videos
Related Concept Videos
lncRNA - Long Non-coding RNAs
lncRNA - Long Non-coding RNAs
siRNA - Small Interfering RNAs
In the cytoplasm, siRNA is processed from a double-stranded RNA, which comes from either endogenous DNA transcription or exogenous sources like a virus. This double-stranded RNA is then cleaved by the...
piRNA - Piwi-interacting RNAs
Nursing Code of Ethics
Small interfering RNAs (siRNA)

